Agarwal Lab

Research focus

NIH R01 · 2025

SCH: Smart Breath- based Diagnosis of Pulmonary Exacerbations in Children with Cystic Fibrosis through Machine Learning: Towards Noninvasive Health Monitoring in Real-Time

Cystic fibrosis (CF) is a genetic disorder that negatively affects young people across the globe. Pulmonary exacerbations (PEx), episodes of decreased lung function accompanied by coughing, increased sputum production, and weight loss, are a hallmark of CF lung disease. Besides negative health impacts, PEx comes with a burden to healthcare costs in the United States and beyond ($10K-$40K USD per episode). Although PEx can be treated with antibiotics, patients still experience decreased quality of life and ultimately reduced survival. A point-of-care, rapid, and accurate test to identify impending PEx that would benefit from treatment could have an impact on families of children with CF and…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.